Imatinib-d8 - CAS 1092942-82-9

Imatinib-d8 (STI571 D8) is a 2H-labeled version of Imatinib. Imatinib is a multi-target receptor tyrosine kinase inhibitor with anti-tumor activity, selectively inhibiting BCR-ABL, v-Abl, PDGFR, c-kit kinases, and is used in chronic myeloid leukemia treatment.

C-Kit, PDGFR, SARS-CoV, Autophagy, Bcr-Abl

Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Autophagy, Microbiology/Virology, Angiogenesis

1092942-82-9

C29H23D8N7O

501.65

N(C=1N=C(C=CN1)C=2C=CC=NC2)C3=CC(NC(=O)C4=CC=C(CN5C(C(N(C)C(C5([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])C=C4)=CC=C3C

-20°C

Ice Packs

Isotope products